ライフサイエンスコーパス: informed consent

1 y assigned to treatment who provided written informed consent).

2 ma exacerbations were recruited after giving informed consent.

3 the area for more than 1 year, and provided informed consent.

4 All patients provided written informed consent.

5 rea for 3 or more years, and able to provide informed consent.

6 tive single-arm study, and patients provided informed consent.

7 proved this HIPAA-compliant study and waived informed consent.

8 board approval and all patients gave written informed consent.

9 r this HIPAA-compliant study, with waiver of informed consent.

10 d this HIPAA-compliant study, with waiver of informed consent.

11 arch ethics committee and was performed with informed consent.

12 een 10 and 11 October 2015 following written informed consent.

13 review board-approved study was exempt from informed consent.

14 Patients gave written informed consent.

15 board approval was obtained, with waiver of informed consent.

16 All patients gave informed consent.

17 ardized questionnaire, and all patients gave informed consent.

18 titutional review board approval and written informed consent.

19 ed for this study; all patients gave written informed consent.

20 nal review boards, and all participants gave informed consent.

21 , with a waiver of the HIPAA requirement for informed consent.

22 study, and all participants provided written informed consent.

23 nge, 70.4-101.2 years) who had given written informed consent.

24 ive study, with waiver of the need to obtain informed consent.

25 nnaire was used to collect data after verbal informed consent.

26 laration Good Clinical Practice with written informed consent.

27 overnment, and all participants gave written informed consent.

28 d-approved study after they provided written informed consent.

29 e study and waived the requirement to obtain informed consent.

30 ew board-approved study received a waiver of informed consent.

31 board and was HIPAA compliant with waiver of informed consent.

32 scarriage, and were willing and able to give informed consent.

33 hics committee approved the study and waived informed consent.

34 approved this study and waived the need for informed consent.

35 proved this study, and all participants gave informed consent.

36 f prospectively acquired data with waiver of informed consent.

37 ional review board and all participants gave informed consent.

38 All subjects provided written informed consent.

39 obtained, with waiver of the need to obtain informed consent.

40 ountability Act compliant study with written informed consent.

41 committee, and all participants gave written informed consent.

42 practical issues in recruitment and written informed consent.

43 t >/= 10 kg, ability to take oral drugs, and informed consent.

44 f 6 major ROP centers whose parents provided informed consent.

45 board approval was obtained, with waiver of informed consent.

46 y depend on risk versus benefit analysis and informed consent.

47 l review board, and all subjects gave signed informed consent.

48 oved by the ethics board and did not require informed consent.

49 retrospective study, with waiver of written informed consent.

50 Participants gave written informed consent.

51 All patients gave written informed consent.

52 ved this retrospective study, with waiver of informed consent.

53 ics committee, and all subjects gave written informed consent.

54 onal review board, and all participants gave informed consent.

55 study and all participants provided written informed consent.

56 pproved the study, and all participants gave informed consent.

57 tional review board-approved with waivers of informed consent.

58 view board, which waived the requirement for informed consent.

59 onal review board waived the requirement for informed consent.

60 and are clinically stable enough to provide informed consent.

61 hared with prospective donors at the time of informed consent.

62 by institutional review boards with written informed consent.

63 titutional review board provided a waiver of informed consent.

64 the institutional review board with patient informed consent.

65 All participants provided written informed consent.

66 ompliant protocol, and all participants gave informed consent.

67 w study and waived the requirement to obtain informed consent.

68 committee, and all participants gave written informed consent.

69 ethics board approved this study and waived informed consent.

70 retrospective study from the requirement for informed consent.

71 institutional review board with a waiver of informed consent.

72 ed clinical trial, and all patients provided informed consent.

73 e collected from the patient after obtaining informed consent.

74 way of overdoses and provide information for informed consent.

75 October 10th and 11th 2015 following written informed consent.

76 icipation in the ICU, of which 1458 provided informed consent.

77 p a chart for a personalized written patient informed consent.

78 and all recruited subjects provided written informed consent.

79 tate donor/recipient matching and to improve informed consent.

80 with paracetamol overdose, and gave written informed consent.

81 d all participating parents provided written informed consent.

82 approval, and all participants gave written informed consent.

83 d all patients or their parents gave written informed consent.

84 nal review board approval, and patients gave informed consent.

85 ics committee, and participants gave written informed consent.

86 iew board, and all participants gave written informed consent.

87 candidacy for surgical intervention provided informed consent.

88 val, and patients in the CLQ cohort provided informed consent.

89 monitoring were included in the study, after informed consent.

90 screening FFDM during 2004-2013 and provided informed consent.

91 I issues posed by portable neuroimaging: (1) informed consent; (2) privacy; (3) capacity to accuratel

92 The study qualified for exception from informed consent (21 Code of Federal Regulations 50.24).

93 After providing informed consent, 24 adult volunteers underwent imaging

94 wing institutional review board approval and informed consent, 26 subjects (16 men, 10 women; mean ag

95 d-approved, prospectively conducted (written informed consent acquired), cross-sectional study perfor

96 mpliant study was performed with a waiver of informed consent after institutional review board approv

97 After informed consent, all patients underwent antiviral thera

98 .4%] male and 116 [49.8%] female; 80 with no informed consent allegation and 153 who cited lack of in

99 The most common informed consent allegations were failure to explain ris

100 Informed consent allegations were significantly associat

101 ty payments, malpractice lawsuits, including informed consent allegations, still present a time, mone

102 One subject withdrew informed consent and 99 subjects (63 males) were analyze

103 Following informed consent and administration of a study questionn

104 Failure to obtain informed consent and associated medical malpractice case

105 mated in prior studies-with implications for informed consent and design for clinical trials targetin

106 Better understanding of LOS is necessary for informed consent and discharge planning.

107 included randomly assigned patients who gave informed consent and excluded those without 6-month outc

108 secutive patients were enrolled after giving informed consent and fulfilling study entry criteria.

109 Materials and Methods Written informed consent and institutional ethics committee appr

110 n nine self-declared healthy volunteers with informed consent and institutional review board approval

111 Parental informed consent and subject assent were obtained from a

112 considerations, including issues surrounding informed consent and the uncertainty of the results of g

113 Risk estimation is critical for appropriate informed consent and varies substantially across living

114 In sum, 971 subjects granted informed consent and were enrolled resulting in 904 nond

115 nasolacrimal duct obstruction who gave fully informed consent and who had no lid malpositions or cana

116 sign adopted for a sham surgery CT; specific informed consent, and economic issues.

117 ivacy, confidentiality, professionalism, and informed consent, and increase the potential for undue i

118 to the adequacy of participant protections, informed consent, and participant understanding of the r

119 patient assessment, shared decision making, informed consent, and preoperative patient optimization,

120 , selecting appropriate endpoints, ethics of informed consent, and regulatory issues.

121 ls and Methods All subjects provided written informed consent, and the protocol was approved by the u

122 e not too impaired to comprehend and provide informed consent, and, for this paper, who tested HIV ne

123 sponse; pain caused by cIAI; able to provide informed consent; and diagnosis of cIAI with sonogram or

124 To investigate the failure to obtain informed consent as an allegation in medical malpractice

125 With informed consent, blood samples were obtained from 50 pa

126 fter institutional review board approval and informed consent, consecutive LT recipients were include

127 he extended follow-up provided their written informed consent (data cutoff: December 31, 2016).

128 After obtaining patient informed consent, demographics, clinical and health-rela

129 benefits; 11% reported conducting a complete informed consent discussion for each procedure.

130 Prerequisites are as follows: obtaining informed consent; evidencing of an allergen by skin pric

131 n criteria were age 1-4 years at the time of informed consent; fasting serum phosphorus concentration

132 Informed consent for cell therapy studies in patients wi

133 26%) felt confident that they obtained valid informed consent for critical care procedures with the u

134 Methods: All patients gave written informed consent for further utility of the biologic mat

135 of stem cell donors who had provided written informed consent for stem cell donation and use of anony

136 All patients provided written informed consent for study participation, the ablation p

137 n to order an Affirm test were enrolled with informed consent for the collection of additional specim

138 0-75 years, 46% (138) male, who gave written informed consent, for 4-year periods following randomisa

139 oved study, all patients with ADPKD provided informed consent; for control subjects, informed consent

140 oval was obtained and all patients signed an informed consent form.

141 titutional review board approval and written informed consent from all participants were obtained.

142 titutional review board approval and written informed consent from all patients were obtained.

143 search ethics committee approval and written informed consent from each subject, were included in thi

144 titutional review board-approved study, with informed consent from patients.

145 After obtaining informed consent from the readers, 12 CT colonography fl

146 ess than 72 hours after intubation following informed consent from their next of kin.

147 ve more permanent injuries compared with the informed consent group (46 [57.5%] vs 63 [42.0%], P = .0

148 control group, and 47.9 [13.3] years in the informed consent group).

149 e, found to have inadequate documentation of informed consent, immediately withdrew consent, or rando

150 r explore what constitutes best practice for informed consent in critical care.

151 an exception from having to acquire explicit informed consent in emergency circumstances.

152 ere is a paucity of literature investigating informed consent in spinal surgery malpractice.

153 s a graphical template for obtaining patient informed consent in the future.

154 d Methods Thirty recruited patients provided informed consent in this institutional review board-appr

155 All patients provided informed consent in this institutional review board-appr

156 Materials and Methods Written informed consent in this institutional review board-appr

157 After informed consent, in one visit, subjects underwent cardi

158 rd-approved retrospective study, with waived informed consent, included 244 patients with pathologica

159 Lack of informed consent is an important cause of medical malpra

160 eat to tribal services eligibility, 4) broad informed consent language, and 5) vague definitions of d

161 esearch staff safety, infection control, the informed consent model, protocol complexity, data collec

162 eview board-approved study, with the written informed consent of all patients, two-dimensional magnet

163 or hepatectomy and to provide a database for informed consent of prospective donors.

164 aged 15 years or older, and provided written informed consent on behalf of themselves and their neona

165 es do not require further ethical oversight, informed consent, or protections for vulnerable persons

166 Patients provided written informed consent, or, at select sites, there was an exce

167 allenges related to surgical care, including informed consent, pain management, difficult diagnoses a

168 valuation framework included optimal pretest informed consent, post-test discussion, cascade testing,

169 erials and Methods All patients gave written informed consent prior to inclusion in this institutiona

170 eeks, and all men were enrolled with written informed consent prior to treatment.

171 d use evidence-based practices and a careful informed consent process when choosing intravitreal anti

172 osure of genetic information; and a detailed informed consent process.

173 of obtaining the information as part of the informed consent process.

174 Informed consent processes should include legally author

175 ndomized in a 1:1 fashion under exception to informed consent regulations to early coronary angiograp

176 ved this retrospective study, and waived the informed consent requirement.

177 st 1, 2012, to July 30, 2014, and waived the informed consent requirement.

178 Women aged 18-60 years who provided written informed consent, resided in the participating cluster c

179 ns have important implications for patients' informed consent rights, clinicians' employment rights,

180 study in which all subjects provided written informed consent, six patients with relapsing-remitting

181 Participants provided written informed consent to a protocol that was approved by a lo

182 ey transplant candidates (KTCs) must provide informed consent to accept kidneys from increased risk d

183 een patients with biopsy-proven PCa provided informed consent to be included in this institutional hu

184 All subjects gave informed consent to participate and were examined using

185 re part of the follow-on clinical trial gave informed consent to participate in a longitudinal neuroi

186 ll players (age range, 52-65 years) provided informed consent to participate in this cross-sectional

187 s had no evidence of having provided written informed consent to participate.

188 ng dementia, and 634 (9.3%) provided written informed consent to participate.

189 All participants provided informed consent to take part in the trial.

190 ls and Methods All participants gave written informed consent to undergo brain magnetic resonance ima

191 uch as IRB disaster preparedness activities, informed consent, vulnerable populations, confidentialit

192 ional review board approval was obtained and informed consent waived for this HIPAA-compliant retrosp

193 ional review board approval was obtained and informed consent waived for this retrospective noninferi

194 In this institutional review board-approved, informed consent-waived, HIPAA-compliant, retrospective

195 University of Toronto Research Ethics Board; informed consent was not required.

196 on and the poor prognosis to the patient, an informed consent was obtained after she opted for medica

197 An informed consent was obtained after she opted for medica

198 Informed consent was obtained for MR imaging.

199 ood challenge test for udon (wheat noodles), informed consent was obtained from 49 subjects.

200 Written informed consent was obtained from 67 consecutive patien

201 had institutional review board approval, and informed consent was obtained from 72 patients with brea

202 onal Research Ethical Committee, and written informed consent was obtained from all individuals.

203 Written informed consent was obtained from all participants befo

204 Informed consent was obtained from all participants.

205 34.3 +/- 6.5 y) were recruited, and written informed consent was obtained from all participants.

206 Written informed consent was obtained from all participants.

207 of Kanton Bern and Kanton Zurich, and signed informed consent was obtained from all participants.

208 ed by the local ethics committee and written informed consent was obtained from all participants.

209 proved by the local ethics board and written informed consent was obtained from all participants.

210 Materials and Methods Written informed consent was obtained from all patients in the M

211 Materials and Methods Written informed consent was obtained from all patients, and the

212 Informed consent was obtained from all patients.

213 l Research Ethics Service Committee; written informed consent was obtained from all patients.

214 institutional review board approval; written informed consent was obtained from all patients.

215 by the local institutional review board, and informed consent was obtained from all patients.

216 approved by the institutional review board; informed consent was obtained from all patients.

217 pproved by our ethics committee, and written informed consent was obtained from all patients.

218 d by the local ethics committee, and written informed consent was obtained from all patients.

219 the institutional review board, and written informed consent was obtained from all study participant

220 cal committees on human studies, and written informed consent was obtained from all subjects before e

221 by the local ethical committee, and written informed consent was obtained from all subjects before e

222 by the local ethics committees, and written informed consent was obtained from all subjects prior to

223 institutional HIPAA-compliant study; written informed consent was obtained from all subjects.

224 Informed consent was obtained from all subjects.

225 Written informed consent was obtained from all subjects.

226 had institutional review board approval, and informed consent was obtained from all subjects.

227 eiden University Medical Center, and written informed consent was obtained from all subjects.

228 d by the local ethics committee, and written informed consent was obtained from each patient.

229 d by the institutional board review; written informed consent was obtained from healthy subjects and

230 Written informed consent was obtained from patients or their par

231 Informed consent was obtained from patients.

232 Informed consent was obtained from potential enrollees.

233 Informed consent was obtained from the patient or next-o

234 Informed consent was obtained prior to enrollment.

235 Materials and Methods After written informed consent was obtained, 8869 women (age range, 29

236 ional review board approval with a waiver of informed consent was obtained, a HIPAA-compliant retrosp

237 datasets were acquired at 3 T after written informed consent was obtained.

238 roved this retrospective study and waiver of informed consent was obtained.

239 , and interviews occurred only after written informed consent was obtained.

240 he institutional research board, and written informed consent was obtained.

241 Written informed consent was obtained.

242 the institutional review board, and written informed consent was obtained.

243 the institutional review boards, and written informed consent was obtained.

244 the prospective study protocol, and written informed consent was obtained.

245 was approved by the ethics review board, and informed consent was obtained.

246 Informed consent was provided according to the last will

247 Written informed consent was provided by all women who entered t

248 mpliant retrospective study, and a waiver of informed consent was received.

249 Written informed consent was waived because all the patients rec

250 onal review board approval was obtained, and informed consent was waived for this HIPAA-compliant ret

251 onal review board approval was obtained, and informed consent was waived in this HIPAA-compliant retr

252 Written informed consent was waived.

253 review board, and the requirement to obtain informed consent was waived.

254 The requirement to obtain informed consent was waived.

255 roved by the institutional review board, and informed consent was waived.

256 chart review, and the requirement to obtain informed consent was waived.

257 board approved this retrospective study and informed consent was waived.

258 pproval was obtained and the requirement for informed consent was waived.

259 ics committee, and the requirement to obtain informed consent was waived.

260 The requirement to obtain written informed consent was waived.

261 tional review board, and the requirement for informed consent was waived.

262 d by the institutional ethics committee, and informed consent was waived.

263 ture of the study, the requirement to obtain informed consent was waived.

264 rg (ethics approval number, S-320/2012), and informed consent was waived.

265 s approved by the local ethics committee and informed consent was waived.

266 was Institutional Review Board approved, and informed consent was waived.

267 review board, and the requirement to obtain informed consent was waived.

268 l review board approved and HIPAA compliant; informed consent was waived.

269 ided informed consent; for control subjects, informed consent was waived.

270 this retrospective HIPAA-compliant study and informed consent was waived.

271 onal review board approval was obtained, and informed consent was waived.

272 tional review board, and the requirement for informed consent was waived.

273 l review board approved; the need for signed informed consent was waived.

274 The need for informed consent was waived.

275 onal review board; the requirement to obtain informed consent was waived.

276 pective, HIPAA-compliant, multicenter study; informed consent was waived.

277 was obtained, and the requirement to obtain informed consent was waived.

278 onal review board approval, and the need for informed consent was waived.

279 onal review board approval, with a waiver of informed consent, was obtained for this analysis of clin

280 s in English or siSwati, and provide written informed consent were eligible for the study.

281 In addition, allegations of informed consent were found to be predictive of a defens

282 onal review board exemption and a waiver for informed consent were granted to the author with an acad

283 All patients who provided informed consent were included in the safety analysis.

284 titutional review board approval and written informed consent were obtained for the Effect of Iso-osm

285 titutional review board approval and written informed consent were obtained from all patients for the

286 titutional review board approval and written informed consent were obtained from all subjects.

287 d Methods After ethical approval and patient informed consent were obtained, two pretreatment T2-weig

288 titutional review board approval and written informed consent were obtained.

289 Ethics approval and informed consent were obtained.

290 Materials and Methods Ethics approval and informed consent were obtained.

291 Institutional ethics committee approval and informed consent were obtained.

292 local ethics committee approval and written informed consent were obtained.

293 hods Institutional review board approval and informed consent were obtained.

294 omographic (CT) angiography and who provided informed consent were prospectively randomized to the us

295 s and Methods Institutional review board and informed consent were waived for this study.

296 n complications influencing the preoperative informed consent were: smoking, operative technique, res

297 ined and eligible individuals, who had given informed consent, were vaccinated and followed up for 21

298 iew board, but may not require patient-level informed consent when the interventions being tested can

299 consent allegation and 153 who cited lack of informed consent) who underwent spinal surgery and filed

300 y the institutional review board and written informed consent with HIPAA authorization was obtained.